Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)

Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)

US Patent 5614372 · Granted Mar 25, 1997

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for active surveillance of prostate cancer2025
Methods and apparatuses for predicting risk of prostate cancer and prostate glan2024
Compositions and methods related to diagnosis of prostate cancer2023
Methods and apparatuses for conducting analyses2020
Methods and apparatuses for predicting risk of prostate cancer and prostate glan2017
Activation of peptide prodrugs by hK22014
Activation of peptide prodrugs by hK22013
Activation of peptide prodrugs by hK22011
Antibody, immunoassay and method for prostate cancer detection2011
Activation of peptide prodrugs by hK22006
Tissue specific prodrug2003
Tissue specific prodrug2002